Halozyme Therapeutics Investor Presentation — September 2021

Document content

Corporate Presentation

September 2021Forward -Looking Statements

2Note: This presentation contains product names, trademarks and registered trademarks are property of their respective ownersIn addition to historical information, the statements set forth in this presentation include forward -looking statements includin g, without limitation, statements

concerning the Company’s expected future financial performance (including the Company's financial outlook for 2021) and expec tations for profitability,

revenue (including expectations for future milestones and royalty growth), operating income, cash flow, expenses and earnings -per-share and the Company’s

plans to continue its share repurchase program and to potentially expand its platform through acquisitions. Forward -looking sta tements regarding the

Company’s ENHANZE® drug delivery technology may include the possible activity, benefits and attributes of ENHANZE®, the possi blemethod of action of

ENHANZE®, its potential application to aid in the dispersion and absorption of other injected therapeutic drugs and facilitat ingmore rapid delivery or larger

volumes of injectable medications through subcutaneous delivery, and lowering the treatment burden for patients and health ca re system costs. Forward -

looking statements regarding the Company's ENHANZE® business may include potential growth driven by our partners' development and commercialization

efforts (including anticipated new clinical trial starts, number of products in development and ENHANZE® product approvals and launches), projections for

future sales revenue of our collaborators’ products, potential new ENHANZE® collaborations, collaborative targets and co -formula tion intellectual property.

These forward -looking statements are typically, but not always, identified through use of the words "believe," "enable," "may," "will," "could," "intends," "estimate,"

"anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of similar meanin g and involve risk and uncertainties that

could cause actual results to differ materially from those in the forward -looking statements. Actual results could differ materi ally from the expectations

contained in these forward -looking statements as a result of several factors, including unexpected levels of revenues (including royalty and milestone revenue

received from our collaboration partners), expenditures and costs, unexpected delays in the execution of the Company's share re purchase program or

planned platform expansion, unexpected results or delays in the growth of the Company’s ENHANZE® business, obtaining new co -form ulation intellectual